Cartesian Growth Corporation III
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CGCT research report →
Price Chart
About the company
Cartesian Growth Corporation III (CGC III) operates as a special purpose acquisition company (SPAC), having been established in 2024 as an exempted entity under Cayman Islands law. Its core mission is to achieve a significant business combination, which may take the form of a merger, share exchange, asset purchase, stock acquisition, corporate reorganization, or similar strategic transaction with one or more existing enterprises or organizations.
- CEO
- Peter Michael Yu
- IPO
- 2025
- Employees
- 2
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on CGCT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $399.10M
- P/E
- 91.26
- PEG
- -0.00
- P/S
- 3991.38
- P/B
- 1.36
- EV/EBITDA
- -1.91
- Div Yield
- 0.00%
- Gross Margin
- -6942.31%
- Op Margin
- -140149.36%
- Net Margin
- -34308.75%
- ROE
- -16.08%
- ROIC
- -29.01%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-1,158,207
- Net Income
- $6.22M+14691.9%
- EPS
- $0.34+28433.3%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $17.17
- 52W Low
- $9.26
- 50D MA
- $10.65
- 200D MA
- $10.30
- Beta
- 0.72
- RSI (14)
- 71
- Avg Volume
- 215.14K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Factorial reported its first commercial revenue ahead of plan, with management highlighting strong aerospace traction, improving cell performance, and a lower full-year spending outlook.· November 10, 2026
- First customer revenue arrived in Q3 2026 at about $26,000 from aerospace shipments, ahead of the company’s prior 2027 timeline.
- Management said aerospace is the first proof point, with more customer qualification work underway and potential expansion to roughly the next 10 customer qualification processes.
- The company said it reached about 450 Wh/kg in its aerospace program cells, above the prior target and about 15% higher than the cells used in its world-record flight.
- Pilot-line yield in Korea is roughly 85%, which management said is above typical lithium-ion pilot-line targets and supports cost improvement as volumes scale.
- Full-year 2026 spending guidance moved lower, with non-GAAP operating expenses now expected at $36 million to $38 million and capex at $10 million to $12 million.
Revenue was approximately $26,000 in the quarter from first shipments under the aerospace order announced in July. Gross loss was $1.8 million, with nearly all of it tied to an inventory write-down. Non-GAAP operating expenses were $9 million for the quarter and $24 million year to date; non-GAAP operating expenses exclude $4.1 million related to previously disclosed legal judgments. GAAP net income was $8.8 million, primarily from a $24 million noncash change in fair value of warrant liability. For the nine months, GAAP net loss was $11.1 million. Full-year 2026 non-GAAP operating expenses are now expected to be $36 million to $38 million, down from prior outlook of about $40 million, and full-year capex is expected to be $10 million to $12 million versus prior outlook of about $13 million.
Siyu Huang framed the quarter as a major milestone because Factorial moved from development into paying customer revenue sooner than expected. She emphasized a go-to-market strategy that starts in high-spec markets like drones and aerospace, then extends into automotive, using partnership, system-level validation, and then commercial orders as the pattern. Her tone was confident and forward-looking, repeatedly pointing to world-record demonstrations, new partnerships, and the company’s ability to replicate the aerospace playbook across more customers and larger markets.
C. Wei focused on the company’s early commercialization model and the economics of scaling. He said Q3 revenue was approximately $26,000, gross loss was $1.8 million, and non-GAAP operating expenses were $9 million for the quarter and $24 million year to date, mostly R&D and operating infrastructure. He also highlighted that full-year 2026 non-GAAP operating expenses are expected at $36 million to $38 million, with capex at $10 million to $12 million, and noted that lower spending partly reflects production costs moving into inventory and cost of revenues rather than operating expenses. He said revenue should remain modest until production programs ramp, with more meaningful commercial revenue expected in 2027.
Analysts pressed management on 2027 revenue visibility, qualification milestones, yield improvement, customer sequencing, and the SK On partnership. Siyu Huang said the company has not disclosed 2027 guidance yet, but expects more meaningful revenue as it scales and is actively qualifying customers, including a potential expansion to the next 10 customer qualification processes. On yield, she said the Korea line is roughly 85% yield over the past two years, but this is assembly/formation only and not a full gigafactory benchmark. Management also said the SK On MOU contains milestones that they cannot disclose, and that the most important near-term milestone is OEM uptake rather than the MOU details.
The bull case from this call is that Factorial has moved from prototype claims to actual customer revenue, and management says the first order came faster than expected. The company also pointed to concrete technical progress, including about 450 Wh/kg in aerospace cells, world-record and challenge wins, and a fab-less manufacturing model with multiple partners that could support scaling without heavy capital intensity.
The bear case is that revenue is still extremely small, gross loss was driven by inventory write-downs, and management said revenue will likely stay modest until production programs ramp in 2027. The company is still early in customer qualification, automotive commercialization remains a longer process, and the SK On relationship is still an MOU with undisclosed milestones rather than a definitive manufacturing agreement.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 100.0%
- Shares Outstanding
- 27.60M
- Float Shares
- 27.60M
of shares held by institutions
64 13F filers
Buy/sell ratio 11.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Clear Street LLC | 476.15K | ▲ 476.15K |
| Oconnor, A Distinct Business Unit Of Ubs Asset Management Americas (LLC) | 250.00K | 0 |
Held by 4 ETFs
Biggest fund positions in CGCT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 21, 26 | CGC III Sponsor LLC | buy | 6,089 |
| May 1, 26 | CGC III Sponsor LLC | other | 8,195 |
| Apr 16, 26 | CGC III Sponsor LLC | buy | 100,000 |
| Apr 15, 26 | CGC III Sponsor LLC | buy | 100,000 |
| Apr 17, 26 | CGC III Sponsor LLC | buy | 28,522 |
| Apr 16, 26 | CGC III Sponsor LLC | buy | 152,100 |
| Apr 15, 26 | CGC III Sponsor LLC | buy | 34,963 |
| Apr 8, 26 | CGC III Sponsor LLC | buy | 100,000 |
| Apr 7, 26 | CGC III Sponsor LLC | buy | 100,000 |
| Apr 6, 26 | CGC III Sponsor LLC | buy | 100,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CGCT coverage
Recent articles, reports, and earnings notes.
No research on CGCT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CGCT report →Cartesian Growth Corp III (NASDAQ:CGCT) Stock Price Up 0.6% – Time to Buy?
defenseworld.net · Jul 23
Factorial and Cartesian Growth Corporation III Announce Approval of Business Combination by Cartesian Growth Shareholders
globenewswire.com · May 27
Replay of UBS Podcast Featuring Factorial CEO Siyu Huang on Solid‑State Technology and Manufacturing Scalability Now Available
globenewswire.com · May 20
Factorial and Cartesian III Registration Statement Declared Effective by SEC in Connection with Proposed Business Combination
globenewswire.com · May 11
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.